Clidinium Bromide: Medgend

Clidinium Bromide FDA Approved Drugs

ANORO ELLIPTA [Umeclidinium Bromide^{C₂₉H₃₄NO₂Br} : Vilanterol Trifenatate^{C₂₄H₃₃Cl₂NO₅C₂₀H₁₆O₂}]

eq 0.0625mg base/inh : eq 0.025mg base/inh (inhalation powder)

Glaxosmithkline^{Dec 18, 2013}

Indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema..

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

INCRUSE ELLIPTA [Umeclidinium Bromide^{C₂₉H₃₄NO₂Br}]

eq 62.5mcg base/inh (inhalation powder)

Glaxo Grp England^{Apr 30, 2014}

Indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema..

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

LIBRAX [Chlordiazepoxide Hydrochloride^{C₁₆H₁₄ClN₃OClH} : Clidinium Bromide^{C₂₂H₂₆NO₃Br}]

5mg : 2.5mg (oral capsule)

Valeant Pharms^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TUDORZA PRESSAIR [Aclidinium Bromide^{C₂₆H₃₀NO₄S₂Br}]

0.4mg/inh (inhalation powder, metered)

Astrazeneca Pharms^{Jul 23, 2012}

Treatment of chronic obstructive pulmonary disease (copd) or chronic bronchitis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.